Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,710,904,874
+$637,928,962 QoQ
Shares Held
10,772,949
+13.0% QoQ
Ownership
0.610%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#24
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 39%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2020CallValue
$76,799
CallShares
1,008
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $18,000,750,668 across 17 Drug Manufacturers - General names. ABBV ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,379,627 | $4,053,626,340 | |
| 2 | JNJ |
Johnson & Johnson
|
15,661,323 | $3,977,506,192 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,772,949 | $2,710,904,874 | |
| 4 | AZN |
Astrazeneca PLC
|
12,640,672 | $2,396,924,218 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,964,180 | $1,537,397,125 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,269,170 | $918,386,928 | |
| 7 | AMGN |
Amgen Inc
|
2,355,705 | $853,047,884 | |
| 8 | PFE |
Pfizer Inc
|
31,492,018 | $758,327,787 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,710,904,874 | 10,772,949 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $2,072,975,912 | 9,531,362 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,314,538,342 | 10,129,714 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,189,449,638 | 9,456,032 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,704,275,032 | 9,181,527 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,933,076,347 | 9,226,214 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,735,969,415 | 9,769,102 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,514,045,383 | 7,666,829 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $1,355,999,377 | 7,905,780 | Shares | Sole | 2025-06-12 | |
| 2024-03-31 | $1,527,326,774 | 8,387,297 | Shares | Sole | 2025-06-02 | |
| 2023-12-31 | $1,122,835,744 | 7,245,504 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $726,639,318 | 4,874,811 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $821,020,494 | 6,093,821 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $887,412,155 | 5,568,251 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $942,009,650 | 5,828,907 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $776,877,260 | 5,788,520 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,013,374,247 | 6,616,442 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $878,250,208 | 5,417,619 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $833,275,966 | 6,154,180 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $658,922,699 | 6,108,489 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $767,010,357 | 6,809,396 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $692,731,794 | 6,401,144 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $908,311,076 | 8,477,005 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,049,696,943 | 11,984,210 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $839,916,737 | 8,554,866 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $76,799 | 1,008 | Call | Defined | 2020-05-14 | |
| 2020-03-31 | $622,608,291 | 8,171,785 | Shares | Other | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||